本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2026/10/221 分钟阅读
Tikva Allocell Selected to Present Preclinical CD19.SB9.CAR-EBVST Data at ACR Convergence 2026
本地自动翻译 · 来源原始语言
摘要
Oral presentation will feature preclinical research evaluating Tikva's armored allogeneic CD19 CAR T-cell therapy as a potential lymphodepletion-free approach for systemic lupus erythematosus SINGAPORE, Oct. 22, 2026…
来源原始语言: PR Newswire — Global News Releases打开原始公告 →